ophthal-360 (Pending FDA Clearance)

Welcome to Ophthal-360, the cutting-edge, fully automated AI-based diagnostic solution that is set to transform ophthalmic care. With Ophthal-360, we bring you the future of diagnostics, utilizing the power of artificial intelligence to provide rapid and accurate diagnoses. While awaiting FDA clearance, Ophthal-360 promises to revolutionize the way we approach ophthalmic diagnostics.

product

Ophthal-360 Autonomous AI

Ophthal-360 is designed to streamline and automate the diagnostic process, eliminating the need for manual interpretation. Our advanced AI algorithms analyze retinal images with exceptional precision, ensuring reliable and consistent results. By leveraging state-of-the-art technology, Ophthal-360 empowers healthcare professionals to make well-informed decisions quickly and efficiently.

While pending FDA clearance, Ophthal-360 is poised to revolutionize ophthalmic diagnostics. Our commitment to delivering innovative, automated solutions ensures that you stay at the forefront of the industry. Experience the future of diagnostics with Ophthal-360 and be ready to elevate the standard of care in ophthalmology.

Ophthal-360 helps save time during the examination of healthy patients by allowing medical personnel with basic training to pre-screen diabetic patients.

Our system is user-friendly for clinicians and non-clinicians.

Get quick and accurate results for automated screening of Diabetic Retinopathy in less than 10 seconds.

Our systems' encrypted data storage and communication ensure that all data is 100 % secure.

Ophthal-360  AI-based Eye Exam

Ophthal-360 is an AI engine that enables accessible retinal exams using ANY camera (including smartphones) and can be conducted by ANYONE without the need for training or skills needed.

Ophthal-360 is a technology that uses AI to detect mild to moderate and vision-threatening diabetic retinopathy in adults with diabetes who haven’t been diagnosed before. This technology aims to make diabetic retinopathy screening more accessible for everyone.

3 Easy Steps:

  • AI-based autonomous eye exam – No doctor is required
  • Optimize efficiency with excellent patient outcome

Ophthal-360 tested with 30+ cameras and mobiles using a low-cost attachable lens.

We Enjoy Working

What People  Say

Implementing Ophthalytics in our hospital has been a game-changer for us. The early detection capabilities for diabetic retinopathy are truly remarkable, allowing us to provide better care to our patients. The user-friendly interface and efficient evaluations of patient data have improved our workflow and saved valuable time for our healthcare professionals. With Ophthalytics, we have experienced significant cost savings on infrastructure upgrades while serving a larger number of patients effectively. Ophthalytics has proven to be a valuable asset in our mission to deliver high-quality eye care services
James Thompson
Eye Hospital Administrator
Ophthalytics has transformed the way I diagnose and manage ophthalmic conditions in my optometry practice. Its advanced AI technology provides accurate and efficient detection of diabetic retinopathy, allowing for early intervention and preventing vision loss. The camera-agnostic feature is fantastic, as it works seamlessly with any camera, giving me flexibility in using my preferred equipment. The speed and accuracy of Ophthalytics make it an invaluable resource, saving me time and improving patient outcomes. I highly recommend Ophthalytics to fellow optometrists
Dr. Jessica Ramirez
Optometrist
Being diagnosed with diabetic retinopathy was a worrying time for me, but Ophthalytics has made a significant difference in managing my condition. The early detection capabilities have allowed for timely interventions, preserving my vision. The process is quick and straightforward, and the user-friendly interface ensures that I can easily understand my assessment results. I am grateful for Ophthalytics and the peace of mind it provides. It has truly been a lifesaver, and I highly recommend it to anyone dealing with diabetic retinopathy.
Emily Roberts
Patient

Preventing Blindness Detecting the Undetectable

Ophthalytics – The Largest AI-powered Eye Disease Platform